Adrian Mollo was Appointed as General Counsel at Osiris Therapeutics

Date of management change: December 03, 2014 

What Happened?

Columbia, MD-based Osiris Therapeutics has Appointed Adrian Mollo as General Counsel


About the Company

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.


About the Person

Adrian Mollo is Senior Vice President and General Counsel at March of Dimes. Previously, Adrian held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Braun Jeffrey, Bregenzer Michael, Cheung Andrew, Baughns Dana, Hussain Mahrukh, Toth Mark, Busk Chadwick, Do Samantha, Egan Margaret, Kosky John, Cucuzza Michelle

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.